HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia

Published:2017-06-05 Issue:1 Volume:32 Page:49-60
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Tharkar-Promod S,Johnson D P,Bennett S E,Dennis E M,Banowsky B G,Jones S S,Shearstone J R,Quayle S N,Min C,Jarpe M,Mosbruger T,Pomicter A D,Miles R R,Chen W Y,Bhalla K N,Zweidler-McKay P A,Shrieve D C,Deininger M W,Chandrasekharan M B,Bhaskara S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2017174.pdf

Reference46 articles.

1. Koretzky GA . The legacy of the Philadelphia chromosome. J Clin Invest 2007; 117: 2030–2032.

2. Mullighan CG . Molecular genetics of B-precursor acute lymphoblastic leukemia. J Clin Invest 2012; 122: 3407–3415.

3. Daver N, Thomas D, Ravandi F, Cortes J, Garris R, Jabbour E et al. Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica 2015; 100: 653–661.

4. Miller GD, Bruno BJ, Lim CS . Resistant mutations in CML and Ph(+)ALL - role of ponatinib. Biologics 2014; 8: 243–254.

5. Lee HZ, Kwitkowski VE, Del Valle PL, Ricci MS, Saber H, Habtemariam BA et al. FDA approval: belinostat for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma. Clin Cancer Res 2015; 21: 2666–2670.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lineage-specific proteome remodeling of diverse lung cancer cells by targeted epigenetic inhibitors;2024-05-28

2. A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens;Hematology;2024-04-06

3. Carrier-free doxorubicin/rhein supramolecular co-assembly for cancer therapy;Journal of Drug Delivery Science and Technology;2023-11

4. Integrated multiomic analysis and high‐throughput screening reveal potential gene targets and synergetic drug combinations for osteosarcoma therapy;MedComm;2023-07-12

5. Research progress on the antitumor effects of astragaloside IV;European Journal of Pharmacology;2023-01